Compared to healthy human livers, expression levels of CXCL9 and FABP4 are upregulated in human NASH livers, and BMP2, NRP1, and VEGFA are downregulated in livers from both NAFLD and NASH patients (Fig. 2C). This evidence concerns the gene VEGFA and metabolic dysfunction-associated steatohepatitis.